Genpact LTD is 2.9x more valuable than Astrana Health, Inc. by market capitalization ($5.46 B vs $1.88 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ASTH | G |
|---|---|---|
| Market cap | $1.88 B | $5.46 B |
| US-listed rank | #2135 | #1323 |
| Revenue (latest FY) | $3.18B | $5.08B |
| Net income (latest FY) | $24.00M | $552.49M |
| Net margin | 0.8% | 10.9% |
| P/E (trailing FY) | 78.3 | 9.9 |
| SEC filings | 1,003 | 1,502 |
Genpact LTD is 2.9x more valuable than Astrana Health, Inc. by market capitalization ($5.46 B vs $1.88 B).
In their latest fiscal years, Astrana Health, Inc. reported $3.18B in revenue while Genpact LTD reported $5.08B.
Full pages: Astrana Health, Inc. and Genpact LTD, or browse the full rankings.